Daron Evans
CIK 1411726 · CFO · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.12M
Companies
4
Total Filings
70
Lifetime Open-Market Net
$739.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RZLT | CFO | 411,462 | $4.00 | $1.65M | $664.7K | 18 | 2026-03-04 |
| NEPH | CEO Specialty Renal Products | 143,162 | $3.34 | $478.2K | $59.9K | 8 | 2021-06-01 |
| CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Chief Financial Officer | 13,352 | — | — | $0 | 4 | 2011-04-19 |
| CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted | Chief Financial Officer | 13,352 | $13.96 | $186.4K | $14.7K | 9 | 2010-02-17 |
Recent Filings · Page 6 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-04-17 | — | Grant (A) | — | $0 | |
| 2014-12-22 | — | Other (J) | +21,239 | $12.7K | |
| 2014-11-07 | — | Grant (A) | +43,194 | $0 | |
| 2014-03-27 | — | Mixed | +2,151 | $645 | |
| 2012-04-02 | — | Buy (P) | +12,500 | $0 | |
| 2011-04-19 | CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-01-05 | CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-07-28 | CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-07-12 | CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-02-17 | CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.